|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/00 | |||
| A61P 19/00 | |||
| A61P 9/00 | |||
| A61P 11/00 | |||
| C07K 16/24 |
| (11) | Patento numeris | 2280732 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09739607.1 |
| Europos patento paraiškos padavimo data | 2009-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-02-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/041981 |
| Data | 2009-04-28 |
| (87) | Numeris | WO 2009/134805 |
| Data | 2009-11-05 |
| (30) | Numeris | Data | Šalis |
| 48522 | 2008-04-28 | US |
| (72) |
BEBBINGTON, Christopher, R., US
LUEHRSEN, Kenneth, US
YARRANTON, Geoffrey, T., US
|
| (73) |
Humanigen, Inc.,
533 Airport Boulevard Suite 400, Burlingame, CA 94010,
US
|
| (54) | ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR |
| ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR |